Seppic comes to rescue of aging face, bust
This article was originally published in The Rose Sheet
Executive Summary
Noting that with age, "the cheeks become hollow and the chest sags," Paris-based subsidiary of Air Liquide introduces Voluform, a 3D "plumping" active ingredient it says can remodel curves of the face and bust, presenting an alternative to cosmetic surgery and Botox injections. Voluform stimulates "functionality" of adipocytes, or fat cells, and prevents loss of volume and fullness, according to information presented at in-cosmetics. "With its plumping effect, it redefines the contours of the face, fills in wrinkles and rounds out the chest with original tautness and firmness," Seppic says. After one month of topical treatment on the bust area, 83% of testers saw increased breast volume, while 60% recorded an average size increase of 0.6 centimeters. Firm is positioning Voluform as "an active ingredient for each generation.